Kentucky 2023 Regular Session Status: In Committee

SB 114 — AN ACT relating to information on emergency use drugs and declaring an emergency.

Last action — to Health Services (S)

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2023 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Create a new section of KRS 217.005 to 217.215 to require that any individual who administers an unapproved drug that has been approved for emergency use by the commissioner of the United States Food and Drug Administration provides information; prohibit any person from being required to have an unapproved drug administered; EMERGENCY.

Bill Text

Action History

  1. to Health Services (S)

  2. to Committee on Committees (S)

  3. introduced in Senate

Sponsorship breakdown

Export CSV (upgrade) →

0 sponsors · 0 co-sponsors · 138 not signed on

Sponsors (0)

None.

Co-sponsors (0)

None.

Not signed on (138)

138 members have not signed on to this bill.

Show all 138 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 114 do?
Create a new section of KRS 217.005 to 217.215 to require that any individual who administers an unapproved drug that has been approved for emergency use by the commissioner of the United States Food and Drug Administration provides information; prohibit any person from being required to have an unapproved drug administered; EMERGENCY.
What is the current status of SB 114?
This bill died with 2023 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track SB 114?
Track SB 114 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 114

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 114

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →